Position in MRK
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$2,813,379
+$105,050 QoQ
Shares Held
21,894
-2.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#1,380
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Traynor Capital Management, Inc. holds $88,098,662 across 9 Drug Manufacturers - General names. MRK ranks #4 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
54,814 | $65,745,561 | |
| 2 | NVO |
Novo Nordisk A S
|
247,912 | $11,884,901 | |
| 3 | ABBV |
AbbVie Inc.
|
19,460 | $4,896,914 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
21,894 | $2,813,379 | |
| 5 | JNJ |
Johnson & Johnson
|
3,240 | $822,862 | |
| 6 | NVS |
Novartis AG
|
5,144 | $806,167 | |
| 7 | PFE |
Pfizer Inc
|
19,204 | $462,432 | |
| 8 | AMGN |
Amgen Inc
|
960 | $347,635 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,813,379 | 21,894 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $2,708,329 | 22,515 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,372,665 | 22,541 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $1,912,177 | 22,783 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $1,663,072 | 21,009 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $2,254,412 | 25,116 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $2,724,359 | 27,386 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $1,522,839 | 13,410 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $1,373,684 | 11,096 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $1,381,516 | 10,470 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $1,118,872 | 10,263 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $1,085,607 | 10,545 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $1,208,017 | 10,469 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $1,100,391 | 10,343 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $1,136,017 | 10,239 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $880,490 | 10,224 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $916,623 | 10,054 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $798,100 | 9,727 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $730,609 | 9,533 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $574,516 | 7,649 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $652,568 | 8,391 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $656,113 | 8,511 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $717,549 | 8,772 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $657,047 | 7,921 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $550,280 | 7,116 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $546,966 | 7,109 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||